Correction
- PMID: 38372200
- DOI: 10.1080/13543784.2024.2319956
Correction
Erratum for
-
Potential of BGB-11417, a BCL2 inhibitor, in hematological malignancies.Expert Opin Investig Drugs. 2024 Feb;33(2):73-77. doi: 10.1080/13543784.2024.2309873. Epub 2024 Jan 26. Expert Opin Investig Drugs. 2024. PMID: 38264792 No abstract available.